Olga S. Zimnyakova

Olga S. Zimnyakova

Auto-generated profile, based on publicly available information

Olga S. Zimnyakova

A. I. Burnazyan Federal Medical and Biophysical Center, Moscow, Russia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2022 in IEEE Transactions on Instrumentation and Measurement
Verified
Journal Article
Closed access
ATAleksandr Talitckii
Aleksandr Talitckii
EKEkaterina Kovalenko
Ekaterina Kovalenko
ASAleksei Shcherbak
Aleksei Shcherbak
AAAnna Anikina
Anna Anikina
EBEkaterina Bril
Ekaterina Bril
ASAndrey Somov
Andrey Somov
Parkinson’s disease (PD) is the second most common neurodegenerative disorder that affects the extrapyramidal motor system. The initial clinical symptoms can appear long before the retirement age, affecting the patients’ ability to continue their work. However, the modern healthcare lacks the apparatus to detect the early signs of the disease, with only selected experts being able to spot the onset. Moreover, even if the disease is detected on time, the current clinical routine has no means of monitoring the progression of the disease, nor the effect of the therapy. In this work, we perform a comparative study of three patient-driven monitoring approaches, including wearable sensors data, video of the routine exercises performed by the patients, and their handwriting – all fine-tuned to detect PD. Aspiring to create an inexpensive clinical workflow, we collect the sensor data using a commercial wearable wireless sensor, and the video and the handwriting data are recorded using a basic smartphone. In the analysis stage, we rely on machine and deep learning methods, using f1 score for gauging the performance of the patient-driven data acquisition approaches. The sensor data analysis demonstrates the best f1 score of 0.93. At the same time, the handwriting and remote video recordings are more comfortable and less time-consuming, offering a sensible trade-off for the patients at the later stages of PD.

16 July 2021 in IEEE Transactions on Instrumentation and Measurement
Verified
Journal Article
Closed access
ATAleksandr Talitckii
Aleksandr Talitckii
AAAnna Anikina
Anna Anikina
EKEkaterina Kovalenko
Ekaterina Kovalenko
ASAleksei Shcherbak
Aleksei Shcherbak
Oscar MayoraOscar Mayora
Oscar Mayora
ASAndrey Somov
Andrey Somov
Our society exhibits a worldwide trait of a quickly growing cohort of patients with neurodegenerative diseases, such as Parkinson’s disease (PD). According to the analysts, there is a plausible “PD pandemic” to occur within the next two decades. Nowadays, the research in the area focuses on how to detect, predict, or classify PD and similar diseases without addressing the point of what activities or exercises a subject should do to improve the performance of these tasks. In this article, we propose a method based on machine learning (ML) and wearable sensors to identify the optimal exercises for the efficient detection of PD in patients. We first define 15 common tasks that are typically used to diagnose PD in modern clinical practice. However, these exercises still carry a high risk of misdiagnosis and, moreover, not all of them work well in the scope of existing ML solutions to support the diagnosis. Herein, we collect the data in a real clinical setting using a compact wearable wireless sensor node entailing a board gyroscope, accelerometer, and magnetometer. Application of ML methods to the collected data reveals three “most efficient” exercises to assist diagnosticians with the highest discriminating power (0.9 ROC AUC in each task). The proposed solution can be implemented as a medical decision support system for real-time PD diagnostics.

22 July 2022 in IEEE Sensors Journal
Verified
Journal Article
Closed access
EKEkaterina Kovalenko
Ekaterina Kovalenko
ASAleksei Shcherbak
Aleksei Shcherbak
ASAndrey Somov
Andrey Somov
EBEkaterina Bril
Ekaterina Bril
OZOlga Zimniakova
Olga Zimniakova
ASAleksandr Samoylov
Aleksandr Samoylov
Machine Learning (ML) algorithms is an emerging tool helping automatically solve detection and classification tasks in myriads of applications. ML is extensively used in medical applications and, in particular, for detecting the Parkinson’s Disease (PD). However, the inference is typically made relying on a single data source. This work explores the results of combining more than one data source type for the diagnosis of PD. Data from the Commercial Off-the-Shelf (COTS) wearable sensors (accelerometer, gyroscope and magnetometer), along with video recordings from 83 patients completing a series of 15 tasks was analyzed with the use of ML methods. Statistical and frequency features were extracted and used to train Random Forest and XGBoost Classifiers. We investigate two use cases on classifying (i) healthy individuals and individuals with the PD, and (ii) PD and essential tremor. The experiment showed that using both the data from wearable sensors and video provided the increase of f1 score up to 18% for differentiating between healthy and PD classes and 21% for differentiating PD and essential tremor classes. At the same time, usage of COTS and ML opens wide vista for patient driven data acquisition and healthcare.

Verified
Journal Article
Open access
PDF file
Julia VavilovaJulia Vavilova
Julia Vavilova
ABAnna Boyko
Anna Boyko
NPNatalya V. Ponomareva
Natalya V. Ponomareva
VFVitaly F. Fokin
Vitaly F. Fokin
EFEkaterina Yu. Fedotova
Ekaterina Yu. Fedotova
ASAlexander Sapozhnikov
Alexander Sapozhnikov
Immunosenescence is a process of remodeling the immune system under the influence of chronic inflammation during aging. Parkinson’s disease (PD) is a common age-associated neurodegenerative disorder and is frequently accompanied by neuroinflammation. On the other hand, cytomegalovirus (CMV), one of the most spread infections in humans, may induce chronic inflammation which contributes to immunosenescence, differentiation and the inflation of T cells and NK cells. Currently, there is no clear understanding of immunosenescence severity in PD patients infected with CMV. In this study, we analyzed differentiation stages and immunosenescence characteristics of T cells and NK cells in 31 patients with mild and moderate PD severity, 33 age-matched and 30 young healthy donors. The PD patients were 100% CMV-seropositive compared to 76% age-matched and 73% young CMV-infected healthy donors. The proportion of effector memory T cells re-expressing CD45RA, CD57+CD56− T cells and CD57+CD56+ T cells was significantly reduced in PD patients compared with CMV-seropositive age-matched healthy individuals. The CD57+CD56− T cell proportion in PD patients was similar to that of CMV-seropositive young healthy donors. Thus, PD is characterized by reduced peripheral blood T cell immunosenescence, even against the background of CMV infection.

23 April 2024 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
EBEkaterina Bril
Ekaterina Bril
NFN.A. Fedotova
N.A. Fedotova
OZO.S. Zimnyakova
O.S. Zimnyakova
OTO.E. Turgunhugaev
O.E. Turgunhugaev
MYM.M. Yusupova
M.M. Yusupova
IYI.G. Yarkova
I.G. Yarkova
Objective. The purpose of the study was to study the frequency of complaints of salivation in patients with Parkinson’s disease (PD) at an outpatient appointment. Material and methods. 89 patients with PD participated in the survey (average age 68.67±8.14 years; average disease duration — 5.35±3.54 yrs). The presence and severity of sialorrhea were assessed according to the original questionnaire. Results. It was shown that only 15.7% of patients with PD complained of drooling on their own; 84.3% of patients did not present active complaints of drooling. Moreover, more than half of them (53.3%) noted complaints of increased salivation upon further active questioning. A survey about the reasons why patients did not complain of drooling showed that almost half of the respondents (45%) believed that the severity of the motor symptoms of the disease was more significant than drooling, 32.5% did not think that this symptom could be associated with Parkinson’s disease, 15% did not think that this symptom could be addressed to a neurologist, 7.5% did not think that this symptom could and should be treated. Conclusion. Barriers to the treatment of sialorrhea in patients are the low awareness of neurologists and patients themselves about treatment options. The use of incobotulinumtoxinA (Xeomin) for the treatment of sialorrhea is currently the first-line treatment method with the highest class of evidence.

1 January 2022 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
EBEkaterina Bril
Ekaterina Bril
AKA.V. Khasina
A.V. Khasina
OZO.S. Zimnyakova
O.S. Zimnyakova
NFN.V. Fedorova
N.V. Fedorova
Patient communication skills are critical for the management of neurological patients, in particular for discussing neurological diagnosis and prognosis. The key communication tools are SPIKES protocol for delivering «bad news» and the Calgary-Cambridge model. These communication tools allow to implement a patient-oriented approach to treatment, build effective communication with the patients, and thus provide them high-quality and personalized medical care.